During the past decade, Central India Cancer Research Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central India Cancer Research Institute" #1 sponsor was "Piramal Enterprises Limited" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Exelixis" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Central India Cancer Research Institute" are "Advanced Refractory Solid Tumors" (2 trials), "Breast Neoplasms" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "Central India Cancer Research Institute" in a lesser frequency.

Most popular intervention types in "Central India Cancer Research Institute" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Afatinib 40mg once daily (OD)" (1 trials), "Amivantamab" (1 trials), "BIBW 2992" (1 trials), "Carboplatin" (1 trials) and "IV Placebo for tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central India Cancer Research Institute" are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Central India Cancer Research Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Central India Cancer Research Institute, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central India Cancer Research Institute, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".